Skip to main content

Advertisement

Table 1 Patient characteristics and univariate analysis

From: The prognostic influence of body mass index, resting energy expenditure and fasting blood glucose on postoperative patients with esophageal cancer

Factors   N 5-year survival (%) p
Age, year ≤65 210 53.3 0.003
>65 96 34.6  
Sex Male 235 44.0 0.039
Female 71 57.8  
Histology AC 98 49.7 0.590
SCC 208 45.7  
Surgical type Transthoracic 186 47.0 0.701
McKeown 53 40.4  
Transabdominal 67 51.2  
Differentiation Well 38 61.9 0.000
Moderately 173 55.1  
Poorly 95 24.9  
T stage Tis/T1 31 82.2 0.000
T2 65 62.1  
T3 159 43.3  
T4a 51 17.1  
N stage N0 156 67.5 0.000
N1 73 38.6  
N2 52 14.2  
N3-4 25 9.5  
TNM stage 0-I 42 80.5 0.000
II 118 66.5  
III 146 21.3  
Weight lost No/Little 203 46.5 0.555
Middle 50 56.8  
Large 53 41.7  
Adjuvant Chemoradiation Yes 78 41.7 0.187
No 228 48.8  
Albumin <35 g/l 36 26.7 0.000
35–40 g/l 132 41.6  
>40 g/l 138 57.8  
Lymphocyte <1.1*109 42 48.7 0.780
1.1–3.2*109 228 47.5  
>3.2*109 36 42.6  
NLR <5 289 47.1 0.787
≥5 17 47.1  
REE/kg <23.2 245 50.4 0.024
≥23.2 61 35.2  
REE Low 154 40.4 0.010
High 152 55.3  
FBG Low 108 35.0 0.020
High 198 51.7  
BMI Low 81 36.8 0.046
Normal 186 49.1  
High 39 62.8  
  1. CI confidence interval, OR odds ratio
  2. The results were in bold, if the 95 % CI excluded 1 or p<0.05